Send to

Choose Destination
Med Clin (Barc). 2014 Mar;142 Suppl 1:59-65. doi: 10.1016/S0025-7753(14)70085-5.

[Complementary treatment of acute heart failure in patients with diabetes, chronic obstructive pulmonary disease or anemia].

[Article in Spanish]

Author information

UGC Medicina Interna, Hospital Juan Ramón Jiménez, Complejo Hospitalario de Huelva, Huelva, España. Electronic address:
Servicio de Medicina Interna, Hospital Vall d'Hebron, Barcelona, España.
Servicio de Medicina Interna, Hospital Municipal de Badalona, Badalona, Barcelona, España.


Diabetes, chronic obstructive pulmonary disease (COPD) and anemia are comorbidities with a high prevalence and impact in heart failure (HF). The presence of these comorbidities considerably worsens the prognosis of HF. Diabetic patients have a higher likelihood of developing symptoms of HF and both the treatment of diabetes and that of acute HF are altered by the coexistence of both entities. The glycemic targets in patients with acute HF are not well-defined, but could show a U-shaped relationship. Stress hyperglycemia in non-diabetic patients with HF could also have a deleterious effect on the medium-term prognosis. The inter-relationship between COPD and HF hampers diagnosis due to the overlap between the symptoms and signs of both entities and complementary investigations. The treatment of acute HF is also altered by the presence of COPD. Anemia is highly prevalent and is often the direct cause of decompensated HF, the most common cause being iron deficiency anemia. Iron replacement therapy, specifically intravenous forms, has helped to improve the prognosis of acute HF.


Acute heart failure; Anemia; COPD; Diabetes; EPOC; Insuficiencia cardíaca aguda; Tratamiento; Treatment

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center